Jupiter Orphan Therapeutics, Inc. — Form D
Jupiter Orphan Therapeutics, Inc. of JUPITER, FL, a company, filed a Form D exempt-offering notice with the SEC on 2017-12-05. The offering totals $100K, of which $100K was reported sold. Industry: Other Health Care.
Offering
- Filed: 2017-12-05
- Form: D
- Accession: 0001679628-17-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $100K
- Amount sold: $100K
- Investors: 1
- Date of first sale: 2017-11-17
- Security types: equity, debt
- Revenue range: Decline to Disclose
- SEC file number: 021-300031
Issuer
- Name: Jupiter Orphan Therapeutics, Inc.
- CIK: 0001679628
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 601 HERITAGE DRIVE, JUPITER, FL, 33458
- Phone: (561) 308-7780
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Marshall Hayward | Director | FREIENBACH, V8 |
| Natalie McNamee | Director | Jupiter, FL |
| Christer Rosen | Director | Schindellegi, V8 |
| Jacob Uittenbogaard | Director | Jupiter, FL |
| Claes Wahlestedt | Director | New York, NY |
| Marshall Hayward | Executive Officer | FREIENBACH, V8 |
| Christer Rosen | Executive Officer | Schindellegi, V8 |
| Jacob Uittenbogaard | Executive Officer | Jupiter, FL |
| Claes Wahlestedt | Executive Officer | New York, NY |
Other filings by this issuer (2)
More